Clinical Trial

Pantoprazole in Cisplatin Nephrotoxicity

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Pantoprazole in Cisplatin Nephrotoxicity
Trial Details
NCT Number NCT04217512
Lead Sponsor Sherief Abd-Elsalam
Conditions Oncology
Enrollment 60 participants
Start Date 2019-05-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2020-01-03